Related Experiment Video
Updated: Jan 17, 2026

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
Published on: October 6, 2023
Interventions to Reduce Pediatric Cancer Treatment Abandonment in Low- and Middle-Income Countries: A Scoping Review
Insights
Pediatric cancer treatment abandonment in low- and middle-income countries (LMICs) can be reduced with multifaceted interventions. Combining socioeconomic support, education, and improved clinical care significantly lowers abandonment rates and improves survival outcomes for children with cancer.
Area of Science:
- Global Health
- Pediatric Oncology
- Health Services Research
Background:
- Pediatric cancer outcomes in low- and middle-income countries (LMICs) are poor compared to high-income countries.
- High treatment abandonment rates contribute significantly to this disparity.
- Treatment abandonment is defined as failing to initiate or complete cancer therapy after diagnosis.
Purpose of the Study:
- To conduct a scoping review of interventions aimed at reducing treatment abandonment in pediatric cancer patients in LMICs.
- To identify and categorize interventions targeting treatment abandonment.
- To evaluate the effectiveness of these interventions on abandonment rates and survival outcomes.
Main Methods:
- Systematic database search for studies on interventions for pediatric cancer treatment abandonment in LMICs.
- Inclusion criteria: interventions on treatment abandonment, patients ≤18 years, LMICs, pre- and post-intervention measures.
- Interventions categorized into socioeconomic support, education/psychosocial support, or clinical care improvements.
Main Results:
- 21 studies met inclusion criteria across WHO regions.
- All interventions demonstrated a decrease in treatment abandonment.
- Combined interventions (socioeconomic, psychosocial, clinical care) showed the largest reduction in abandonment (median ARR 16%, median RRR 72%).
- Pre-intervention abandonment rate decreased from a median of 27% to 7% post-intervention.
- 10 studies reported increased survival outcomes following interventions.
Conclusions:
- Multifaceted interventions combining socioeconomic support, psychosocial support, and clinical care quality improvements are effective in reducing pediatric cancer treatment abandonment in LMICs.
- Treatment abandonment is a modifiable challenge in LMICs.
- Implementing comprehensive interventions can improve survival outcomes for children with cancer in resource-limited settings.
Background:
Pediatric cancer treatment outcomes in low- and middle-income countries (LMICs) significantly lag behind those in high-income countries. One reason for this disparity is high treatment abandonment rates, defined as a failure to start or complete curative-intent therapy after a cancer diagnosis. We conducted a scoping review to describe interventions aimed at reducing treatment abandonment in pediatric cancer patients in LMICs.
Methods:
Studies identified through systematic database search were included if they met the following criteria: (a) studied an intervention on treatment abandonment; (b) included cancer patients ≤18 years of age; (c) conducted in LMICs as defined by the World Bank income classification; (d) contained pre- and post-intervention measures of treatment abandonment. We restricted inclusion to English-language publications. Two reviewers independently screened the eligible publications and extracted the data. Interventions were categorized as focusing on socioeconomic support, education/psychosocial support, or clinical care quality and capacity improvements (e.g., care navigation, coordination, or therapeutic/diagnostic expansion).
Findings:
Among the 1,808 articles identified in the search, 21 studies met inclusion criteria: four from the WHO African region, nine from the Americas, seven from the South-East Asian, and three from the Western Pacific Region. Sixteen studies (66%) focused on one category for improvement, and eight (34%) were a mixture of two or more categories. All studies demonstrated a decrease in treatment abandonment after the intervention. The median absolute risk reduction (ARR) was 16% (interquartile range [IQR] 10%-24%). The median relative risk reduction was 72% (IQR 60%-82%). The median pre-intervention abandonment rate across full-text studies was 27% (IQR 20%-34%) and decreased to 7% (IQR 3%-12%) after intervention. Interventions with the largest ARR values included components of socioeconomic support, psychosocial support, and clinic care improvements. All of the 10 studies reporting pre- and post-intervention survival outcomes reported increases in survival following the intervention.
Interpretation:
Our scoping review describes interventions that were associated with reduced pediatric cancer treatment abandonment in LMICs. Interventions that combined socioeconomic support, psychosocial support, and clinical care quality/capacity improvements yielded the largest reductions. Despite these encouraging findings, limitations of the evidence, including short study durations, single-center designs, lack of control groups, and likely publication bias, restrict the generalizability of results. These findings suggest that treatment abandonment is a targetable and potentially modifiable challenge in LMICs, and that survival outcomes can improve when health systems adopt multifaceted interventions that support families and strengthen care delivery.
Funding:
National Institutes of Health, K12CA090433.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Pharmacokinetics in Pediatric Patients: Drug Excretion
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
